Cost of bespoke medicines cut by law change

NHS spending on medicines made up for individual patients is set to fall following legislation allowing price lists to be published.

Manufacturers of ‘specials’, unlicensed medicines manufactured for individual patients with specific needs, were previously not allowed to publicise availability of products.

Spending on such products has tripled in the past two years, as a result of increased outsourcing of manufacturing and rising delivery costs.

In May, GP exclusively revealed that the DoH is now working with the Pharmaceutical Services Negotiating Committee (PSNC) to amend national reimbursement arrangements. Bringing costs down to 2007 levels would save the NHS £107m a year.

The PSNC said that changing the law to allow publication of price lists could help address cost issues.

‘This change has the potential to ease the current problems pharmacy contractors face in procuring these products by improving pharmacy contractor access to information on both the availability and cost of specials from different suppliers.’

The committee said it is encouraging specials manufacturers to publish price lists where practical. But, it recognised that, because of the bespoke nature of some products, this may not be possible in all cases.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Dr Vasumathy Sivarajasingam explains why screening for domestic abuse should be standard...

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...